{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"riboflavin-transporter-deficiency","columns":[{"gene":"","key":"population-ad9fc4fb7376e75763a4","label":"Riboflavin transporter deficiency","mondoId":"MONDO:0008891","onsetQualifier":null,"originColumnKey":"MONDO:0008891/ORPHA:97229","originalViews":[{"key":"MONDO:0008891/ORPHA:97229","label":"Riboflavin transporter deficiency","scopeLabel":"ORPHA:97229","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["06c580e2c621467efee81300a671a12aca66e197bb1b5d4c5fc905ee99d385a4","0a6d8fcd84f4d48649f7487defc57643f6d473baff2a96f8ccb70692db4a26b8","0d037910c9fa0686620f787e3007af2ccc47ab7b62b533a63b759e7fb1252de5","111fbc90b7a01a88ea0300faf721afb3586fffd87061a6e229e848e30d108084","23f6ffccaf30a1d61e000342f472f9aec66d59f1a14720fca8d7bd57a0c8499e","2a56ed030dfb56c29723f3dc4d55b303125e12df3c2514bd4d89ec74cc95ea30","2d97590edd18ef4c410fe26a80e48dd5b39e3e1573c7d27c15c5a477ddfac412","2f56cd0795481f14dea39f1904ffe409bd3fc7ecf41d5c9535ed793ab7087ee5","3564b7f744fd1d0761c83c9ab0eadec264df650e09d4b0ede7d81975e83cb875","3865843cfa9cc4c25aa129efeeacbb3c903b0b56189197955636c7cf934d844d","4eaf6219d88b56a3e990bdb42f26343992f7f7607fed2762458cf4bfe80eb9c0","51eac3a7ae90eb56237e433967981d8b044c1d5f7071fb400f08c07567bd0b46","574fc18840d0598acee2df16c65462a2e1e0603108d377ad38891307f9c852ee","62ebd526fcaad1deecdf3765a348224619b8c4a874724e18afde21cff68a4b23","668043f3998879132f48956ac0c161af6c5afc182f3358e6c30dc2c8aa4ba9da","68686da0da2b6268eb20ce00db576c57ef15db68cb65165e2ddef63dac7bb127","7a7245b9c94840f8398b8a33e8854840daa70ad100e7fd27f87f5516b376079a","813985e1fb405c5e76ea166783ce69616c9ba76819e32db1a57268c7eeb8aacd","88cc776e938545a25c829e52d1ffaea065663b375b27012239e97eb91df53378","906c185757a7bb62d9f2de48b3140acc61e6b5a5fe10fcb16ff620aa6799d5a1","9a1958e5fb30e111934d08936a23c03573e2b766ce543f950092b75c33d000cc","b2254169c8fb83c9fcf1ff61fca1a4f809fbb7120f236aa5836fadc585df10c4","b5f9c6773965a58e7ba59774a6bc4d3f4aacf643a1a61d9368a764dccda0267c","bc8a2d37a4b9fb77ca8f9a1bc1129a1e2811a56854b4dc33f86671dd75f89760","c2ee9f20501c3cf887af38ca08bef4ab6facf23a8837abbdb2276d3a97fc7ba0","ca4ddcb8d05c2a2178e2b98e15b9a312f366cadd5c9b5ef55fd39465364b8e44","cf3e1252809c519f2d5cc52681beb69fe868d9f6e519411de724c2e273a86fb9","d6781a4ca254f392488976bd85cd6f7ef278c3332d346627a42ff04e7edca70a","dcc61f77c548bf89f32077651fd82f50b9e193bf624409ff81ab97904de190e6","dcc72173aad48a81bf6b9ed7db1782783de1b0423b1918b26948064de7a2aef1","eb0ca2acf68afeb2038770f661b13f415c443fbfb47dc2652e624b412b9ff022","edeabda5503ee8d52ee539b71c220a4ba07c631a50c2a253cba2f14d666bb2ed","eff0339bd39d40b5ddeb9ba8bffaa0f3bd1b68482d7428efc2f457718388ae35","f94adc215f6aa8322cc30d89673a2ddba5884039a2944f7459b78820ab2b9126","f97fa8aef665f60f57f58a05c012f9e21bcc56c9f8cd799fa6e4c45b304061c2"],"recordQualifiers":{},"scopeLabel":"ORPHA:97229","sourceIds":["ORPHA:97229"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-ad9fc4fb7376e75763a4"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0012332","HP:0001291","HP:0008002","HP:0000496","HP:0000718","HP:0001251","HP:0001283"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":35,"sourceGroups":{"orphanet":35}},"features":[{"hpoId":"HP:0012332","label":"Abnormal autonomic nervous system physiology","primary":true},{"hpoId":"HP:0001291","label":"Abnormal cranial nerve morphology","primary":true},{"hpoId":"HP:0008002","label":"Abnormal macular pigmentation","primary":true},{"hpoId":"HP:0000496","label":"Abnormality of eye movement","primary":true},{"hpoId":"HP:0000718","label":"Aggressive behavior","primary":true},{"hpoId":"HP:0001251","label":"Ataxia","primary":true},{"hpoId":"HP:0001283","label":"Bulbar palsy","primary":true},{"hpoId":"HP:0004326","label":"Cachexia","primary":false},{"hpoId":"HP:0002120","label":"Cerebral cortical atrophy","primary":false},{"hpoId":"HP:0000551","label":"Color vision defect","primary":false},{"hpoId":"HP:0006824","label":"Cranial nerve paralysis","primary":false},{"hpoId":"HP:0000873","label":"Diabetes insipidus","primary":false},{"hpoId":"HP:0001260","label":"Dysarthria","primary":false},{"hpoId":"HP:0002015","label":"Dysphagia","primary":false},{"hpoId":"HP:0010628","label":"Facial palsy","primary":false},{"hpoId":"HP:0000771","label":"Gynecomastia","primary":false},{"hpoId":"HP:0000738","label":"Hallucinations","primary":false},{"hpoId":"HP:0000822","label":"Hypertension","primary":false},{"hpoId":"HP:0000135","label":"Hypogonadism","primary":false},{"hpoId":"HP:0001265","label":"Hyporeflexia","primary":false},{"hpoId":"HP:0001252","label":"Hypotonia","primary":false},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":false},{"hpoId":"HP:0007730","label":"Iris hypopigmentation","primary":false},{"hpoId":"HP:0003690","label":"Limb muscle weakness","primary":false},{"hpoId":"HP:0001324","label":"Muscle weakness","primary":false},{"hpoId":"HP:0001336","label":"Myoclonus","primary":false},{"hpoId":"HP:0000543","label":"Optic disc pallor","primary":false},{"hpoId":"HP:0001730","label":"Progressive hearing impairment","primary":false},{"hpoId":"HP:0000508","label":"Ptosis","primary":false},{"hpoId":"HP:0002093","label":"Respiratory insufficiency","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0003202","label":"Skeletal muscle atrophy","primary":false},{"hpoId":"HP:0010535","label":"Sleep apnea","primary":false},{"hpoId":"HP:0001337","label":"Tremor","primary":false},{"hpoId":"HP:0000505","label":"Visual impairment","primary":false}],"ledeHtml":"Riboflavin transporter deficiency neuronopathy is a disorder that affects nerve cells (neurons). Affected individuals typically have hearing loss caused by nerve damage in the inner ear (sensorineural hearing loss) and signs of damage to other nerves. In addition to nerves in the inner ear, riboflavin transporter deficiency neuronopathy involves nerves found in the part of the brain that is connected to the spinal cord (the brainstem), specifically in a region of the brainstem known as the pontobulbar region. Damage to these nerves causes paralysis of the muscles controlled by them, a condition called pontobulbar palsy. Nerves in the pontobulbar region help control several voluntary muscle activities, including breathing, speaking, and moving the limbs. As a result of pontobulbar palsy, people with riboflavin transporter deficiency neuronopathy can have breathing problems; slurred speech; and muscle weakness in the face, neck, shoulders, and limbs. Affected individuals can also have muscle stiffness (spasticity) and exaggerated reflexes. The age at which riboflavin transporter deficiency neuronopathy begins varies from infancy to young adulthood. When the condition begins in infancy, the first symptom is often breathing problems caused by nerve damage, which can be life-threatening. When the condition begins in children or young adults, sensorineural hearing loss usually occurs first, followed by signs of pontobulbar palsy. If not treated, the signs and symptoms of riboflavin transporter deficiency neuronopathy worsen over time. Severe breathing problems and respiratory infections are the usual cause of death in people with this condition. Without treatment, affected infants typically survive less than one year. However, those who develop the condition after age 4 often survive more than 10 years. Riboflavin transporter deficiency neuronopathy encompasses two conditions that were once considered distinct disorders: Brown-Vialetto-Van Laere syndrome (BVVLS) and Fazio-Londe disease. The two conditions have similar signs and symptoms, but Fazio-Londe disease does not include sensorineural hearing loss. Because these two conditions share a genetic cause and have overlapping features, researchers determined that they are forms of a single disorder.","mondoId":"MONDO:0008891","node":{"canonicalSlug":"riboflavin-transporter-deficiency","comparisons":[{"documentSha256":"84519a82b4b98731f380e99b2f9eb58a371f26c6495d5a3d71745c4313aec153","key":"prepared-riboflavin-transporter-deficiency","kind":"prepared","label":"riboflavin transporter deficiency","memberIds":["MONDO:0008890","MONDO:0008891","MONDO:0013867","MONDO:0024537","MONDO:0100428"],"mondoId":"MONDO:0008891","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-84519a82b4b98731f380.84519a82b4b98731f380e99b2f9eb58a371f26c6495d5a3d71745c4313aec153.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Riboflavin transporter deficiency","originalSourceId":"ORPHA:97229","paragraphs":["Riboflavin transporter deficiency neuronopathy is a disorder that affects nerve cells (neurons). Affected individuals typically have hearing loss caused by nerve damage in the inner ear (sensorineural hearing loss) and signs of damage to other nerves. In addition to nerves in the inner ear, riboflavin transporter deficiency neuronopathy involves nerves found in the part of the brain that is connected to the spinal cord (the brainstem), specifically in a region of the brainstem known as the pontobulbar region. Damage to these nerves causes paralysis of the muscles controlled by them, a condition called pontobulbar palsy. Nerves in the pontobulbar region help control several voluntary muscle activities, including breathing, speaking, and moving the limbs. As a result of pontobulbar palsy, people with riboflavin transporter deficiency neuronopathy can have breathing problems; slurred speech; and muscle weakness in the face, neck, shoulders, and limbs. Affected individuals can also have muscle stiffness (spasticity) and exaggerated reflexes. The age at which riboflavin transporter deficiency neuronopathy begins varies from infancy to young adulthood. When the condition begins in infancy, the first symptom is often breathing problems caused by nerve damage, which can be life-threatening. When the condition begins in children or young adults, sensorineural hearing loss usually occurs first, followed by signs of pontobulbar palsy. If not treated, the signs and symptoms of riboflavin transporter deficiency neuronopathy worsen over time. Severe breathing problems and respiratory infections are the usual cause of death in people with this condition. Without treatment, affected infants typically survive less than one year. However, those who develop the condition after age 4 often survive more than 10 years. Riboflavin transporter deficiency neuronopathy encompasses two conditions that were once considered distinct disorders: Brown-Vialetto-Van Laere syndrome (BVVLS) and Fazio-Londe disease. The two conditions have similar signs and symptoms, but Fazio-Londe disease does not include sensorineural hearing loss. Because these two conditions share a genetic cause and have overlapping features, researchers determined that they are forms of a single disorder."],"rawAttribution":"MONDO:0008891","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-22T14:56:18Z","upstream":"GARD:0009993","url":"https://rarediseases.info.nih.gov/diseases/9993"},"ownColumnKeys":["population-ad9fc4fb7376e75763a4"],"publication":"published","relationships":[{"kind":"parent","label":"hereditary motor neuron disease","mondoId":"MONDO:0024257","slug":"hereditary-motor-neuron-disease"},{"kind":"child","label":"progressive bulbar palsy","mondoId":"MONDO:0008890","slug":"progressive-bulbar-palsy"},{"kind":"child","label":"Brown-Vialetto-van Laere syndrome 2","mondoId":"MONDO:0013867","slug":"brown-vialetto-van-laere-syndrome-2"},{"kind":"child","label":"Brown-Vialetto-van Laere syndrome 1","mondoId":"MONDO:0024537","slug":"riboflavin-transporter-deficiency-neuronopathy"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Clinical-characteristics text absent or chapter identity requires review","source":"GeneReviews","url":"https://www.ncbi.nlm.nih.gov/books/NBK299312/"}],"translation":"published"},"records":[{"frequencyKind":"range","key":"06c580e2c621467efee81300a671a12aca66e197bb1b5d4c5fc905ee99d385a4","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003690","is_excluded":false,"label":"Limb muscle weakness","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0a6d8fcd84f4d48649f7487defc57643f6d473baff2a96f8ccb70692db4a26b8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001260","is_excluded":false,"label":"Dysarthria","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0d037910c9fa0686620f787e3007af2ccc47ab7b62b533a63b759e7fb1252de5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"111fbc90b7a01a88ea0300faf721afb3586fffd87061a6e229e848e30d108084","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0008002","is_excluded":false,"label":"Abnormal macular pigmentation","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"23f6ffccaf30a1d61e000342f472f9aec66d59f1a14720fca8d7bd57a0c8499e","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001730","is_excluded":false,"label":"Progressive hearing impairment","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2a56ed030dfb56c29723f3dc4d55b303125e12df3c2514bd4d89ec74cc95ea30","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000738","is_excluded":false,"label":"Hallucinations","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2d97590edd18ef4c410fe26a80e48dd5b39e3e1573c7d27c15c5a477ddfac412","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001283","is_excluded":false,"label":"Bulbar palsy","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2f56cd0795481f14dea39f1904ffe409bd3fc7ecf41d5c9535ed793ab7087ee5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0010628","is_excluded":false,"label":"Facial palsy","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3564b7f744fd1d0761c83c9ab0eadec264df650e09d4b0ede7d81975e83cb875","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000135","is_excluded":false,"label":"Hypogonadism","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3865843cfa9cc4c25aa129efeeacbb3c903b0b56189197955636c7cf934d844d","raw":{"aspect":"P","body_system":"breast","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000771","is_excluded":false,"label":"Gynecomastia","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4eaf6219d88b56a3e990bdb42f26343992f7f7607fed2762458cf4bfe80eb9c0","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002093","is_excluded":false,"label":"Respiratory insufficiency","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"51eac3a7ae90eb56237e433967981d8b044c1d5f7071fb400f08c07567bd0b46","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000551","is_excluded":false,"label":"Color vision defect","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"574fc18840d0598acee2df16c65462a2e1e0603108d377ad38891307f9c852ee","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000508","is_excluded":false,"label":"Ptosis","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"62ebd526fcaad1deecdf3765a348224619b8c4a874724e18afde21cff68a4b23","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"668043f3998879132f48956ac0c161af6c5afc182f3358e6c30dc2c8aa4ba9da","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"68686da0da2b6268eb20ce00db576c57ef15db68cb65165e2ddef63dac7bb127","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000543","is_excluded":false,"label":"Optic disc pallor","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7a7245b9c94840f8398b8a33e8854840daa70ad100e7fd27f87f5516b376079a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"813985e1fb405c5e76ea166783ce69616c9ba76819e32db1a57268c7eeb8aacd","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001336","is_excluded":false,"label":"Myoclonus","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"88cc776e938545a25c829e52d1ffaea065663b375b27012239e97eb91df53378","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000873","is_excluded":false,"label":"Diabetes insipidus","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"906c185757a7bb62d9f2de48b3140acc61e6b5a5fe10fcb16ff620aa6799d5a1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002120","is_excluded":false,"label":"Cerebral cortical atrophy","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9a1958e5fb30e111934d08936a23c03573e2b766ce543f950092b75c33d000cc","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0004326","is_excluded":false,"label":"Cachexia","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b2254169c8fb83c9fcf1ff61fca1a4f809fbb7120f236aa5836fadc585df10c4","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001324","is_excluded":false,"label":"Muscle weakness","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b5f9c6773965a58e7ba59774a6bc4d3f4aacf643a1a61d9368a764dccda0267c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001265","is_excluded":false,"label":"Hyporeflexia","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bc8a2d37a4b9fb77ca8f9a1bc1129a1e2811a56854b4dc33f86671dd75f89760","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000718","is_excluded":false,"label":"Aggressive behavior","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c2ee9f20501c3cf887af38ca08bef4ab6facf23a8837abbdb2276d3a97fc7ba0","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0007730","is_excluded":false,"label":"Iris hypopigmentation","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ca4ddcb8d05c2a2178e2b98e15b9a312f366cadd5c9b5ef55fd39465364b8e44","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001291","is_excluded":false,"label":"Abnormal cranial nerve morphology","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cf3e1252809c519f2d5cc52681beb69fe868d9f6e519411de724c2e273a86fb9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012332","is_excluded":false,"label":"Abnormal autonomic nervous system physiology","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d6781a4ca254f392488976bd85cd6f7ef278c3332d346627a42ff04e7edca70a","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000822","is_excluded":false,"label":"Hypertension","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"dcc61f77c548bf89f32077651fd82f50b9e193bf624409ff81ab97904de190e6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002015","is_excluded":false,"label":"Dysphagia","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"dcc72173aad48a81bf6b9ed7db1782783de1b0423b1918b26948064de7a2aef1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001337","is_excluded":false,"label":"Tremor","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"eb0ca2acf68afeb2038770f661b13f415c443fbfb47dc2652e624b412b9ff022","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0010535","is_excluded":false,"label":"Sleep apnea","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"edeabda5503ee8d52ee539b71c220a4ba07c631a50c2a253cba2f14d666bb2ed","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000496","is_excluded":false,"label":"Abnormality of eye movement","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"eff0339bd39d40b5ddeb9ba8bffaa0f3bd1b68482d7428efc2f457718388ae35","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003202","is_excluded":false,"label":"Skeletal muscle atrophy","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f94adc215f6aa8322cc30d89673a2ddba5884039a2944f7459b78820ab2b9126","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000505","is_excluded":false,"label":"Visual impairment","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f97fa8aef665f60f57f58a05c012f9e21bcc56c9f8cd799fa6e4c45b304061c2","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:97229","disease_name":"Riboflavin transporter deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0006824","is_excluded":false,"label":"Cranial nerve paralysis","onset_id":null,"reference":"ORPHA:97229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/9993\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0008891\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0009993</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Riboflavin transporter deficiency neuronopathy is a disorder that affects nerve cells (neurons). Affected individuals typically have hearing loss caused by nerve damage in the inner ear (sensorineural hearing loss) and signs of damage to other nerves. In addition to nerves in the inner ear, riboflavin transporter deficiency neuronopathy involves nerves found in the part of the brain that is connected to the spinal cord (the brainstem), specifically in a region of the brainstem known as the pontobulbar region. Damage to these nerves causes paralysis of the muscles controlled by them, a condition called pontobulbar palsy. Nerves in the pontobulbar region help control several voluntary muscle activities, including breathing, speaking, and moving the limbs. As a result of pontobulbar palsy, people with riboflavin transporter deficiency neuronopathy can have breathing problems; slurred speech; and muscle weakness in the face, neck, shoulders, and limbs. Affected individuals can also have muscle stiffness (spasticity) and exaggerated reflexes. The age at which riboflavin transporter deficiency neuronopathy begins varies from infancy to young adulthood. When the condition begins in infancy, the first symptom is often breathing problems caused by nerve damage, which can be life-threatening. When the condition begins in children or young adults, sensorineural hearing loss usually occurs first, followed by signs of pontobulbar palsy. If not treated, the signs and symptoms of riboflavin transporter deficiency neuronopathy worsen over time. Severe breathing problems and respiratory infections are the usual cause of death in people with this condition. Without treatment, affected infants typically survive less than one year. However, those who develop the condition after age 4 often survive more than 10 years. Riboflavin transporter deficiency neuronopathy encompasses two conditions that were once considered distinct disorders: Brown-Vialetto-Van Laere syndrome (BVVLS) and Fazio-Londe disease. The two conditions have similar signs and symptoms, but Fazio-Londe disease does not include sensorineural hearing loss. Because these two conditions share a genetic cause and have overlapping features, researchers determined that they are forms of a single disorder.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/9993\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"riboflavin-transporter-deficiency","sourceDocuments":[{"name":"GARD: Riboflavin transporter deficiency","reviewed":null,"source_release":"2026-10-22T14:56:18Z","url":"https://rarediseases.info.nih.gov/diseases/9993"},{"name":"MONDO: riboflavin transporter deficiency","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0008891"}],"sourceNote":"","synonyms":["Brown-Vialetto-van Laere syndrome","Brown-Vialetto-Van Laere syndrome 1","BVVLS","BVVLS1","disorder of riboflavin transmembrane transporter activity","Fazio-Londe syndrome","pontobulbar palsy and neurosensory deafness","progressive bulbar palsy with sensorineural deafness","riboflavin transmembrane transporter activity disease","sensorineural hearing loss-pontobulbar palsy syndrome"],"takeawayHtml":"","title":"riboflavin transporter deficiency"},"schemaVersion":1}
